X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1137) 1137
index medicus (931) 931
rats (724) 724
male (696) 696
hypoxia-ischemia, brain - drug therapy (685) 685
neurosciences (651) 651
humans (648) 648
animals, newborn (562) 562
female (533) 533
disease models, animal (437) 437
hypoxia-ischemia (418) 418
brain (400) 400
neuroprotection (383) 383
hypoxia-ischemia, brain - pathology (360) 360
hypoxia-ischemia, brain - metabolism (353) 353
infant, newborn (349) 349
hypoxia-ischemia, brain - physiopathology (347) 347
rats, sprague-dawley (345) 345
neuroprotective agents - pharmacology (343) 343
ischemia (332) 332
neuroprotective agents - therapeutic use (287) 287
pediatrics (276) 276
brain - drug effects (269) 269
apoptosis (250) 250
hypoxia (236) 236
rats, wistar (236) 236
neurology (233) 233
brain - pathology (231) 231
stroke (226) 226
hypoxia-ischemia, brain - therapy (223) 223
infants (213) 213
clinical neurology (205) 205
mice (203) 203
brain - metabolism (193) 193
brain-injury (193) 193
injuries (192) 192
treatment outcome (188) 188
neurons - drug effects (186) 186
time factors (186) 186
hypothermia (180) 180
hypoxia-ischemia, brain - complications (180) 180
article (179) 179
encephalopathy (177) 177
neurons (173) 173
brain damage (168) 168
focal cerebral-ischemia (166) 166
apoptosis - drug effects (163) 163
injury (155) 155
cell-death (147) 147
brain injury (144) 144
hypoxic-ischemic encephalopathy (140) 140
damage (136) 136
oxidative stress (134) 134
pregnancy (131) 131
cerebral-ischemia (130) 130
analysis (129) 129
brain - physiopathology (129) 129
dose-response relationship, drug (127) 127
hypoxia-ischemia, brain - etiology (121) 121
health aspects (120) 120
neurons - metabolism (119) 119
hypoxia-ischemia, brain - prevention & control (118) 118
inflammation (113) 113
neurons - pathology (111) 111
rodents (111) 111
care and treatment (105) 105
research (103) 103
hypothermia, induced (97) 97
model (96) 96
pharmacology & pharmacy (95) 95
asphyxia (93) 93
newborn (91) 91
hippocampus - drug effects (90) 90
neuroprotective agents - administration & dosage (90) 90
hypothermia, induced - methods (89) 89
rat (89) 89
immunohistochemistry (88) 88
neonates (88) 88
cells, cultured (86) 86
expression (86) 86
traumatic brain injury (85) 85
cell biology (84) 84
cerebral ischemia (84) 84
in-vitro (84) 84
biochemistry & molecular biology (81) 81
electroencephalography (81) 81
neonatal hypoxia-ischemia (81) 81
erythropoietin (80) 80
neonatal encephalopathy (80) 80
central-nervous-system (79) 79
cell death (77) 77
rat-brain (77) 77
seizures (75) 75
brain ischemia - drug therapy (74) 74
hippocampus - pathology (74) 74
infant (74) 74
random allocation (74) 74
activation (73) 73
oxidative stress - drug effects (72) 72
perinatal asphyxia (72) 72
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1489) 1489
Chinese (47) 47
Russian (25) 25
Spanish (10) 10
Japanese (6) 6
Danish (2) 2
Bulgarian (1) 1
Dutch (1) 1
French (1) 1
German (1) 1
Norwegian (1) 1
Polish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatrics, ISSN 0031-4005, 06/2016, Volume 137, Issue 6, pp. e20160191 - e20160191
Journal Article
Neuropharmacology, ISSN 0028-3908, 12/2015, Volume 99, pp. 38 - 50
Previous studies have demonstrated that the early suppression of HIF-1α after hypoxia–ischemia (HI) injury provides neuroprotection. Vitexin (5, 7,... 
Hypoxia-inducible factor | Hypoxia–ischemia | Vitexin | Neonatal rat | Hypoxia-ischemia | Capillary Permeability - physiology | Neurons - pathology | Blood-Brain Barrier - physiopathology | Capillary Permeability - drug effects | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Vascular Endothelial Growth Factor A - metabolism | Hypoxia-Ischemia, Brain - pathology | Apigenin - chemistry | Neuroprotective Agents - pharmacology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Neurons - physiology | Atrophy - drug therapy | Cell Death - drug effects | Drug Evaluation, Preclinical | Neurons - drug effects | Disease Models, Animal | Animals, Newborn | Atrophy - physiopathology | Neuroprotective Agents - chemistry | Maze Learning - physiology | Brain - physiopathology | Brain Edema - pathology | Hypoxia-Ischemia, Brain - drug therapy | Treatment Outcome | Random Allocation | Maze Learning - drug effects | Blood-Brain Barrier - drug effects | Rats, Sprague-Dawley | Brain - drug effects | Blood-Brain Barrier - pathology | Animals | Brain Edema - physiopathology | Cell Death - physiology | Brain - pathology | Brain Edema - drug therapy | Apigenin - pharmacology | Hypoxia-Ischemia, Brain - physiopathology | Medicinal plants | Immunohistochemistry | Brain | Ischemia | Immunoglobulin G | Physiological aspects | Permeability | Vascular endothelial growth factor | Injuries
Journal Article
Pediatrics, ISSN 0031-4005, 08/2009, Volume 124, Issue 2, pp. e218 - e226
OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of erythropoietin in neonatal hypoxic-ischemic encephalopathy (HIE), by using a... 
Neonates | Asphyxia | Erythropoietin | Hypoxic-ischemic encephalopathy | NEURONAL APOPTOSIS | BRAIN-INJURY | FETAL SHEEP | neonates | CEREBROSPINAL-FLUID | asphyxia | STROKE | BIRTH-WEIGHT INFANTS | NEONATAL ENCEPHALOPATHY | PHARMACOKINETICS | hypoxic-ischemic encephalopathy | PEDIATRICS | CEREBRAL-ISCHEMIA | DOSE RECOMBINANT ERYTHROPOIETIN | erythropoietin | Brain Damage, Chronic - diagnosis | Prospective Studies | Follow-Up Studies | Humans | Developmental Disabilities - prevention & control | Erythropoietin - adverse effects | Infant | Male | Recombinant Proteins | Asphyxia Neonatorum - drug therapy | Dose-Response Relationship, Drug | Intensive Care Units, Neonatal | Asphyxia Neonatorum - diagnosis | China | Injections, Subcutaneous | Female | Developmental Disabilities - diagnosis | Psychomotor Disorders - prevention & control | Infant, Newborn | Disability Evaluation | Erythropoietin - administration & dosage | Drug Administration Schedule | Hypoxia-Ischemia, Brain - drug therapy | Hypoxia-Ischemia, Brain - diagnosis | Psychomotor Disorders - diagnosis | Neurologic Examination - drug effects | Infusions, Intravenous | Brain Damage, Chronic - prevention & control | Babies | Pediatrics | Developmental psychology | Clinical trials | Glycoproteins | Drug therapy | Drug dosages | Clinical outcomes | Effectiveness studies | Developmental Disabilities | Hypoxia-Ischemia | Brain | Neonatal | MEDICIN OCH HÄLSOVETENSKAP | administration & dosage | Asphyxia Neonatorum | MEDICAL AND HEALTH SCIENCES | Recombinant | Drug | Intensive Care Units | drug therapy | Intravenous | Subcutaneous | Infusions | diagnosis | drug effects | prevention & control | Chronic | Injections | Newborn | Neurologic Examination | adverse effects | Dose-Response Relationship | Brain Damage | Psychomotor Disorders
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2015, Volume 14, Issue 5, pp. 469 - 477
Journal Article
Frontiers in Neuroendocrinology, ISSN 0091-3022, 2008, Volume 30, Issue 1, pp. 65 - 91
Abstract DHEA and DHEAS are steroids synthesized in human adrenals, but their function is unclear. In addition to adrenal synthesis, evidence also indicates... 
Endocrinology & Metabolism | DHEA | Neuroprotection | Dehydroepiandrosterone | DHEAS | Schizophrenia | Depression | Cortisol | Neurogenesis | Apoptosis | Dementia | POSTTRAUMATIC-STRESS-DISORDER | LINKED-IMMUNOSORBENT-ASSAY | TREATED SCHIZOPHRENIA-PATIENTS | NECROSIS-FACTOR-ALPHA | DWELLING OLDER MEN | NEUROSCIENCES | ACTIVATED-RECEPTOR-ALPHA | NEUROACTIVE STEROIDS | ENDOCRINOLOGY & METABOLISM | CENTRAL-NERVOUS-SYSTEM | CORONARY-ARTERY-DISEASE | METHYL-D-ASPARTATE | Dehydroepiandrosterone - pharmacology | Dementia - drug therapy | Humans | Middle Aged | Dehydroepiandrosterone Sulfate - pharmacology | Hypoxia-Ischemia, Brain - drug therapy | Dehydroepiandrosterone - therapeutic use | Male | Dehydroepiandrosterone - physiology | Antioxidants - pharmacology | Brain - drug effects | Brain - metabolism | Depression - drug therapy | Animals | Neuroprotective Agents - pharmacology | Stress Disorders, Post-Traumatic - drug therapy | Aging | Adult | Female | Aged | Schizophrenia - drug therapy | Hydrogen peroxide | Peptides | Streptozocin | Depression, Mental | Leukemia | ACTH | Oxides | Nerve growth factor | Sodium nitroferricyanide | Hormones | Sulfates | Post-traumatic stress disorder | Health aspects | Protein kinases | Glutathione | Protein binding | Epinephrine | Corticosteroids | Endothelium | Methyl aspartate | Androgens | Nitric oxide | GABA | Acetylcholine | Hydroxylases | Mitogens | Literature Review | Psychiatric Disorders | Neuroendocrinology | Glucocorticoids | cortisol | neuroprotection | neurogenesis | apoptosis | dementia | depression | schizophrenia
Journal Article
Neurology, ISSN 0028-3878, 2014, Volume 82, Issue 16, pp. 1425 - 1433
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 12/2014, Volume 34, Issue 49, pp. 16467 - 16481
Journal Article